|
TNKS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.549600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.126600E-01 |
| Normal-vs-Stage2 |
6.029800E-01 |
| Normal-vs-Stage3 |
5.759200E-03 |
| Normal-vs-Stage4 |
1.298070E-03 |
| Stage1-vs-Stage2 |
7.633800E-01 |
| Stage1-vs-Stage3 |
2.101700E-03 |
| Stage1-vs-Stage4 |
1.197150E-03 |
| Stage2-vs-Stage3 |
1.439240E-01 |
| Stage2-vs-Stage4 |
7.956000E-02 |
| Stage3-vs-Stage4 |
6.383200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.208500E-02 |
| Normal-vs-AfricanAmerican |
2.388300E-02 |
| Normal-vs-Asian |
5.060600E-01 |
| Caucasian-vs-AfricanAmerican |
2.106200E-01 |
| Caucasian-vs-Asian |
2.806000E-01 |
| AfricanAmerican-vs-Asian |
9.368300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.707500E-02 |
| Normal-vs-Female |
2.052000E-01 |
| Male-vs-Female |
6.290200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.248200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.937400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.153800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.719700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.675200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.374600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.315590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.270000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.028400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.606300E-02 |
| Normal-vs-Grade 2 |
8.833600E-01 |
| Normal-vs-Grade 3 |
4.278600E-03 |
| Normal-vs-Grade 4 |
2.189400E-04 |
| Grade 1-vs-Grade 2 |
1.917610E-01 |
| Grade 1-vs-Grade 3 |
1.363010E-03 |
| Grade 1-vs-Grade 4 |
2.955200E-04 |
| Grade 2-vs-Grade 3 |
2.608800E-04 |
| Grade 2-vs-Grade 4 |
1.94725999999035E-05 |
| Grade 3-vs-Grade 4 |
7.916400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.637400E-01 |
| Normal-vs-ccB subtype |
3.548000E-02 |
| ccA subtype-vs-ccB subtype |
1.636040E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.822850E-01 |
| Normal-vs-N1 |
2.550200E-01 |
| N0-vs-N1 |
4.310800E-01 |
|
|
